Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2296)
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
52,823
Price
$25.72
Total Value
$1.36M
Shares Held After
76,651
% of Holdings
40.8%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,438
Price
$15.02
Total Value
$36.61K
Shares Held After
0
% of Holdings
100.0%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
2,438
% of Holdings
50.0%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
373
Price
$34.73
Total Value
$12.95K
Shares Held After
102,363
% of Holdings
0.4%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
6,566
Price
$14.00
Total Value
$91.92K
Shares Held After
8,617
% of Holdings
43.2%
Legend Biotech Corp (LEGN)
Casey Patrick John — Director
Shares
6,000
Price
$14.80
Total Value
$88.80K
Shares Held After
48,604
% of Holdings
11.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
4,654
Price
$20.00
Total Value
$93.08K
Shares Held After
51,776
% of Holdings
8.2%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
101,050
Price
$21.12
Total Value
$2.13M
Shares Held After
308,504
% of Holdings
24.7%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
23,365
Price
$7.08
Total Value
$165.42K
Shares Held After
86,380
% of Holdings
21.3%
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
405
Price
$22.00
Total Value
$8.91K
Shares Held After
15,441
% of Holdings
2.6%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
300
Price
$22.00
Total Value
$6.60K
Shares Held After
115,409
% of Holdings
0.3%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
600
Price
$57.09
Total Value
$34.25K
Shares Held After
40,000
% of Holdings
1.5%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
29,400
Price
$56.44
Total Value
$1.66M
Shares Held After
40,600
% of Holdings
42.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
2,554
Price
$57.10
Total Value
$145.84K
Shares Held After
459,399
% of Holdings
0.6%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
97,446
Price
$56.50
Total Value
$5.51M
Shares Held After
461,953
% of Holdings
17.4%
Shattuck Labs, Inc. (STTK)
Pandite Arundathy N. — Chief Medical Officer
Shares
30,000
Price
$7.01
Total Value
$210.30K
Shares Held After
136,219
% of Holdings
18.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
100
Price
$2.50
Total Value
$250.00
Shares Held After
2,559,875
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
25,930
Price
$2.54
Total Value
$65.86K
Shares Held After
2,559,775
% of Holdings
1.0%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
50,000
Price
$19.09
Total Value
$954.50K
Shares Held After
225,857
% of Holdings
18.1%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
20,000
Price
$8.84
Total Value
$176.80K
Shares Held After
845,559
% of Holdings
2.3%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
10,000
Price
$34.90
Total Value
$349.00K
Shares Held After
42,963
% of Holdings
18.9%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
55
Price
$1.54
Total Value
$84.70
Shares Held After
72,590
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
545
Price
$1.54
Total Value
$839.30
Shares Held After
718,989
% of Holdings
0.1%
Pyxis Oncology, Inc. (PYXS)
Dupont Jakob — Director
Shares
35,000
Price
$3.06
Total Value
$107.10K
Shares Held After
38,741
% of Holdings
47.5%
ABEONA THERAPEUTICS INC. (ABEO)
Alland Leila — Director
Shares
11,000
Price
$5.92
Total Value
$65.09K
Shares Held After
162,614
% of Holdings
6.3%
CERUS CORP (CERS)
Greenman William Mariner — Director
Shares
101,919
Price
$2.94
Total Value
$299.94K
Shares Held After
5,053,036
% of Holdings
2.0%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,681
Price
$70.00
Total Value
$397.67K
Shares Held After
9,756
% of Holdings
36.8%
CERUS CORP (CERS)
Jayaraman Vivek K — Chief Operating Officer
Shares
42,359
Price
$2.94
Total Value
$124.66K
Shares Held After
1,694,348
% of Holdings
2.4%
CERUS CORP (CERS)
Jensen Chrystal — Chief Legal Officer
Shares
24,329
Price
$2.94
Total Value
$71.60K
Shares Held After
966,657
% of Holdings
2.5%
CERUS CORP (CERS)
Green Kevin Dennis — Chief Financial Officer
Shares
33,676
Price
$2.94
Total Value
$99.11K
Shares Held After
1,062,188
% of Holdings
3.1%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Christianson Mark — Market Development Director
Shares
10,000
Price
$3.18
Total Value
$31.77K
Shares Held After
20,692
% of Holdings
32.6%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
3,200
Price
$117.70
Total Value
$376.65K
Shares Held After
244,883
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
6,153
Price
$116.99
Total Value
$719.86K
Shares Held After
248,083
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
7,971
Price
$115.82
Total Value
$923.18K
Shares Held After
254,236
% of Holdings
3.0%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
51,375
Price
$114.77
Total Value
$5.90M
Shares Held After
262,207
% of Holdings
16.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
4,110
Price
$114.19
Total Value
$469.31K
Shares Held After
313,582
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,100
Price
$112.79
Total Value
$124.07K
Shares Held After
317,692
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,700
Price
$111.57
Total Value
$189.66K
Shares Held After
318,792
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,500
Price
$110.54
Total Value
$165.81K
Shares Held After
320,492
% of Holdings
0.5%
Dogecoin Cash, Inc. (CBDS)
TOBIAS DAVID — Director
Shares
150,000
Price
$0.01
Total Value
$1.27K
Shares Held After
24,143,200
% of Holdings
0.6%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
28,826
Price
$16.04
Total Value
$462.29K
Shares Held After
139,372
% of Holdings
17.1%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
17,060
Price
$46.43
Total Value
$792.10K
Shares Held After
25,996
% of Holdings
39.6%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
4,107
Price
$46.49
Total Value
$190.93K
Shares Held After
25,996
% of Holdings
13.6%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
20,000
Price
$46.40
Total Value
$928.00K
Shares Held After
148,235
% of Holdings
11.9%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
10,000
Price
$46.46
Total Value
$464.60K
Shares Held After
168,235
% of Holdings
5.6%
Ridgetech Inc. (RDGT)
HRT FINANCIAL LP — 10% Owner
Shares
30,939
Price
$1.52
Total Value
$47.03K
Shares Held After
90,302
% of Holdings
34.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
55,121
Price
$8.01
Total Value
$441.52K
Shares Held After
190,130
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
525,844
Price
$8.01
Total Value
$4.21M
Shares Held After
1,813,795
% of Holdings
22.5%
Showing 1–50 of 2296 transactions (page 1 of 46)